Terbinafine Hydrochloride Cream
Product Images NDC 51672-2140

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 51672-2140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Terbinafine 01)

An instructional illustration depicting a foot with an emphasis on the toes, highlighting areas commonly affected by fungal infections, used to guide the topical application of Terbinafine Hydrochloride 1 g/100 g cream for treating such conditions on the foot.*

FDA Label Image

Figure (Terbinafine 02)

An anatomical illustration showing a human foot from the side view with two marked points indicating application sites on the top and side of the foot, likely depicting areas for topical application of the medication.*

FDA Label Image

Principal Display Panel (15 g Tube Carton)

Packaging label for Terbinafine Hydrochloride Cream 1%, an antifungal cream from Sun Pharmaceutical Industries, Inc. The carton highlights it cures most ringworm and compares its active ingredient to Lamisil AT. The net weight is 1/2 oz (15 g). Distributed by Taro Pharmaceuticals U.S.A., Inc., this topical cream is shown with usage and drug facts instructions on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.